UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

Science (American Association for the Advancement of Science), 2001-04, Vol.292 (5514), p.69-74

2001

Volltextzugriff (PDF)

Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates

npj vaccines, 2022-11, Vol.7 (1), p.152-13, Article 152

2022

Volltextzugriff (PDF)

Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking

Journal of Virology, 2013-09, Vol.87 (18), p.10163-10172

2013

Volltextzugriff (PDF)

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Journal of Virology, 2003-10, Vol.77 (20), p.11244-11259

2003

Volltextzugriff (PDF)

ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

Journal of Virology, 2002-01, Vol.76 (1), p.292-302

2002

Volltextzugriff (PDF)

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

Scientific reports, 2019-12, Vol.9 (1), p.20005-15, Article 20005

2019

Volltextzugriff (PDF)

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life

Mucosal immunology, 2013-07, Vol.6 (4), p.692-703

2013

Volltextzugriff (PDF)

Efficacy of DNA and Fowlpox Virus Priming/Boosting Vaccines for Simian/Human Immunodeficiency Virus

Journal of Virology, 2004-12, Vol.78 (24), p.13819-13828

2004

Volltextzugriff (PDF)

Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination

Mucosal immunology, 2009-11, Vol.2 (6), p.536-550

2009

Volltextzugriff (PDF)

Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge

Mucosal immunology, 2016-01, Vol.9 (1), p.13-23

2016

Volltextzugriff (PDF)

The role of antibodies in HIV vaccines

Annual review of immunology, 2010-01, Vol.28 (1), p.413-444

2010

Volltextzugriff (PDF)

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

Nature (London), 2002-01, Vol.415 (6869), p.335-339

2002

Volltextzugriff (PDF)

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells

Mucosal immunology, 2016-03, Vol.9 (2), p.414-427

2016

Volltextzugriff (PDF)

Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection

Journal of Virology, 2001-11, Vol.75 (21), p.10200-10207

2001

Volltextzugriff (PDF)

Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age

Future virology, 2023-07, Vol.18 (10), p.615-620

2023

Volltextzugriff (PDF)

Postnatal Passive Immunization of Neonatal Macaques with a Triple Combination of Human Monoclonal Antibodies against Oral Simian-Human Immunodeficiency Virus Challenge

Journal of Virology, 2001-08, Vol.75 (16), p.7470-7480

2001

Volltextzugriff (PDF)

Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d

Journal of Virology, 2003-02, Vol.77 (3), p.2046-2055

2003

Volltextzugriff (PDF)

Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus Monkeys

Journal of Virology, 2004-07, Vol.78 (14), p.7490-7497

2004

Volltextzugriff (PDF)

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults

AIDS research and human retroviruses, 2006-07, Vol.22 (7), p.678-683

2006

Volltextzugriff (PDF)

The antibody response in HIV-1 infection

AIDS (London), 1997, Vol.11 Suppl A, p.S87-S98

1997

Volltextzugriff (PDF)

Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization

Journal of Virology, 2002-06, Vol.76 (11), p.5357-5368

2002

Volltextzugriff (PDF)

Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion

The Journal of infectious diseases, 2015-03, Vol.211 (6), p.947-955

2015

Volltextzugriff (PDF)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER

Retrovirology, 2014-02, Vol.11 (1), p.16-16

2014

Volltextzugriff (PDF)

Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

Journal of Virology, 2002-06, Vol.76 (12), p.6138-6146

2002

Volltextzugriff (PDF)

1 – 25 von 597

Suche als RSS-Feed

Aktive Filter

ThemaNeutralization Tests

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(585)
Mit Volltextzugriff
(537)

Publikationsform

Artikel
(590)
Tagungsberichte
(7)

Sprache

Englisch
(596)
Japanisch
(55)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(396)
Life Sciences & Biomedicine
(343)
Humans
(239)
Animals
(228)
Virology
(212)
Hiv-1 - Immunology
(157)
Human Immunodeficiency Virus
(156)
Macaca Mulatta
(153)
Immunology
(149)
Aids Vaccines - Immunology
(138)
Hiv
(137)
Vaccines
(127)
Biological And Medical Sciences
(118)
Microbiology
(111)
Human Immunodeficiency Virus 1
(109)
Antibodies
(102)
Infectious Diseases
(97)
Female
(92)
Simian Immunodeficiency Virus - Immunology
(91)
Aids/hiv
(88)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life

Efficacy of DNA and Fowlpox Virus Priming/Boosting Vaccines for Simian/Human Immunodeficiency Virus

Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination

Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge

The role of antibodies in HIV vaccines

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells

Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection

Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age

Postnatal Passive Immunization of Neonatal Macaques with a Triple Combination of Human Monoclonal Antibodies against Oral Simian-Human Immunodeficiency Virus Challenge

Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d

Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus Monkeys

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults

The antibody response in HIV-1 infection

Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization

Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER

Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine

Aktive Filter

Suchergebnisse filtern